EMD-47521

Single-particle
3.7 Å
EMD-47521
3D View Gallery
Deposition: 25/10/2024
Map released: 18/06/2025
Last modified: 16/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-47521
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9e4z summary report (pdf.gz) Map and 9e4z FULL report (pdf.gz)
EMICSS annotations (xml)

GluA2-gamma2 complex bound glutamate and cyclothiazide

EMD-47521

Single-particle
3.7 Å
EMD-47521
3D View Gallery
Deposition: 25/10/2024
Map released: 18/06/2025
Last modified: 16/07/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Rattus norvegicus, Mus musculus
Sample: GluA2-TARPgamma2 Complex bound to glutamate and cyclothiazide
Fitted models: 9e4z

Deposition Authors: Montano Romero A, Carrillo E , Jayaraman V , Twomey EC
Memantine inhibits calcium-permeable AMPA receptors.
Carrillo E , Montano Romero A, Gonzalez CU , Turcu AL , Vazquez S , Twomey EC , Jayaraman V
(2025) Nat Commun , 16 , 5576 - 5576
PUBMED: 40593487
DOI: doi:10.1038/s41467-025-60543-5
ISSN: 2041-1723